Potential Impact of the Medicare Prescription Payment Plan for Medicare Part D Beneficiaries With a Cancer Diagnosis
Early-year entry into catastrophic coverage is common among beneficiaries with certain high-cost cancers. M3P may most effectively reduce financial burden when enrollment occurs before January. Targeted outreach from cancer care teams and Part D plans to nonadherent patients and those considering costly therapies could maximize program impact and improve treatment outcomes.
Authors
- S. D. Ramsey
- Nico Gabriel (ORCID: https://orcid.org/0000-0003-1793-2245)
- Dana B. Mukamel (ORCID: https://orcid.org/0000-0003-4147-5785)
- Aryana Sepassi (ORCID: https://orcid.org/0000-0003-0149-7824)
- Jason A. Zell
- Sean D. Sullivan
- A. Mark Fendrick
Institutions
- University of Washington (US)
- University of California, Irvine (US)
- Fred Hutch Cancer Center (US)
- Michigan Medicine (US)
- Irvine University (US)
- University of Montana (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1200/jco-25-01788
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00